Reglagene mainly engages in transforming tubulin therapy for brain diseases.
Reglagene has raised $767K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Reglagene's investors include Tech Coast Angels, Viva BioInnovator.
Reglagene is headquartered in Tucson, United States.
Reglagene mainly engages in transforming tubulin therapy for brain diseases.
Reglagene is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reglagene — Funding & Investors." VCBacked, May 21, 2024, https://www.vcbacked.co/company/reglagene. Accessed August 15, 2026.
VCBacked. (2024). Reglagene — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/reglagene
{{cite web |title=Reglagene — Funding & Investors |url=https://www.vcbacked.co/company/reglagene |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated